Debt-to-equity of Innovation1 Biotech Inc. from 31 May 2016 to 29 Feb 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Innovation1 Biotech Inc. quarterly Debt-to-equity in % history and change rate from 31 May 2016 to 29 Feb 2024.
Innovation1 Biotech Inc. Debt-to-equity for the quarter ending 29 Feb 2024 was -148%, a 180% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Innovation1 Biotech Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	-148%	-333%	-180%	29 Feb 2024
Q4 2023	-308%	-451%	-315%	30 Nov 2023
Q3 2023	768%	+642%	+509%	31 Aug 2023
Q2 2023	629%	+532%	+549%	31 May 2023
Q1 2023	185%			28 Feb 2023
Q4 2022	143%			30 Nov 2022
Q3 2022	126%			31 Aug 2022
Q2 2022	97%			31 May 2022
Q3 2017	-135%	-23%	-21%	31 Aug 2017
Q2 2017	-104%	+7%	+6.4%	31 May 2017
Q1 2017	-105%			28 Feb 2017
Q4 2016	-107%			30 Nov 2016
Q3 2016	-112%			31 Aug 2016
Q2 2016	-111%			31 May 2016

* An asterisk sign (*) next to the value indicates that the value is likely invalid.